Not great. One of my worst picks from 2020 but a good lesson to cut hard and cut fast as I should have done with the first miss late last year. Assuming telecommunications has bottomed rather than continuing to decline (seems unlikely) and Comdain delivers the 15% revenue increase, and that margins stay the same (and aren't trending down - particularly telco, though I think that unlikely) my estimates have FY21 EBITDA at $88m which is below most expectations I can find.
Posters here have raised very good questions about disclosures from management regarding past issues and it continues today. I may be wrong but while procurement and contracting delays from COVID have been covered in the past, particularly with respect to Comdain, I don't believe the company has made mention of 'shortages of client supplied materials' before.
I think I'm out of this one but it will be a little painful lesson to learn.
- Forums
- ASX - By Stock
- SSM
- Ann: Service Stream HY2021 Results Announcement
SSM
service stream limited
Add to My Watchlist
0.26%
!
$1.95

Ann: Service Stream HY2021 Results Announcement, page-10
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.95 |
Change
0.005(0.26%) |
Mkt cap ! $1.201B |
Open | High | Low | Value | Volume |
$1.94 | $1.95 | $1.91 | $3.734M | 1.924M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 16080 | $1.93 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.95 | 33594 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 16080 | 1.930 |
3 | 42442 | 1.925 |
1 | 16797 | 1.920 |
1 | 2000 | 1.905 |
2 | 1981 | 1.850 |
Price($) | Vol. | No. |
---|---|---|
1.975 | 4000 | 1 |
1.980 | 15000 | 1 |
1.990 | 12000 | 1 |
2.000 | 110173 | 18 |
2.010 | 11166 | 3 |
Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
Featured News
SSM (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online